Larvol Delta - Study-of-AdRTShIL12--Veledimex-in-Combination-With-Cemiplimab-in-Subjects-With-Recurrent-or-Progressive-Glioblastoma

Ad-RTS-hIL-12 - Ziopharm

veledimex (INXN-1001) - Ziopharm

Libtayo (cemiplimab) - Sanofi, Regeneron

http://clinicaltrials.gov/ct2/show/NCT04006119

Nov 11, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next